US 7132392
Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain
granted A61KA61K38/05A61K38/06
Quick answer
US patent 7132392 (Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K38/05, A61K38/06, A61K38/07, A61P